Security record · archived quarter
JANX
Janux Therapeutics, Inc. · Healthcare · Biotechnology
9Tracked holders
n/aΔ holders
5.15MShares held
$215.67MReported value
+0New positions
−0Exits
All ownership figures: tracked 13F managers only, common-stock positions, reporting period Q2 2024
Ownership over time
| Quarter | Holders | Δ | Shares | Reported value | New | Exits |
|---|---|---|---|---|---|---|
| Q2 2026 | 77 | 0 | 35.14M | $539.55M | +6 | −6 |
| Q1 2026 | 80 | +4 | 31.30M | $434.70M | +12 | −8 |
| Q4 2025 | 75 | +1 | 36.09M | $498.13M | +1 | n/a |
| Q3 2025 | 15 | 0 | 27.21M | $664.97M | n/a | n/a |
| Q2 2025 | 12 | 0 | 25.28M | $583.88M | +1 | −1 |
| Q1 2025 | 9 | -2 | 8.77M | $236.76M | n/a | −2 |
| Q4 2024 | 11 | 0 | 8.88M | $475.25M | +1 | −1 |
| Q3 2024 | 10 | +1 | 4.53M | $205.89M | +1 | n/a |
| Q2 2024 | 9 | n/a | 5.15M | $215.67M | n/a | n/a |
Who holds it · Q2 2024
| # | Manager | Shares | Δ shares | Value | Their weight | Held | ||
|---|---|---|---|---|---|---|---|---|
| 1 | Adage Capital Partners ✦ | 2.33M | n/a | $97.52M | 0.2% | n/c | 1 | SEC ↗ |
| 2 | Citadel Advisors ✦ | 1.56M | n/a | $65.23M | 0.1% | n/c | 1 | SEC ↗ ×2 |
| 3 | Geode Capital Management ✦ (passive) | 624.10K | n/a | $26.15M | 0.0% | n/c | 1 | SEC ↗ ×2 |
| 4 | T. Rowe Price ✦ | 252.36K | n/a | $10.57M | 0.0% | n/c | 1 | SEC ↗ ×2 |
| 5 | Point72 Asset Management ✦ | 136.43K | n/a | $5.72M | 0.0% | n/c | 1 | SEC ↗ |
| 6 | Two Sigma Investments ✦ | 103.60K | n/a | $4.34M | 0.0% | n/c | 1 | SEC ↗ |
| 7 | D. E. Shaw & Co. ✦ | 97.82K | n/a | $4.10M | 0.0% | n/c | 1 | SEC ↗ |
| 8 | Wellington Management ✦ | 43.93K | n/a | $1.84M | 0.0% | n/c | 1 | SEC ↗ ×2 |
| 9 | AQR Capital Management ✦ | 5.12K | n/a | $214,686 | 0.0% | n/c | 1 | SEC ↗ ×3 |
“Their weight” = the position's share of that manager's reported 13F equity value: the conviction measure. ✦ = curated manager.
New buyers
| No new tracked buyers this quarter. |
Exited
| No tracked exits this quarter. |
Full-market context: across ALL 13F filers (SEC structured data, Q1 2026): 188 holders, 59.36M shares, $809.28M reported. This is a different, older period than the tracked-universe figures above and the two are never mixed.
Frequently co-owned
What else this security's tracked holders most often hold: shared-ownership counts, not fundamental relationships.
Provenance: Ownership from parsed 13F common-stock positions (tracked universe, comparable sets for changes); insider rows from Forms 3/4/5; stakes from Schedules 13D/13G; every filing links to its original on SEC EDGAR.
Reporting period: Q2 2024 ·
Methodology ·
Get this via the API